A novel lysosomal phospholipase A2 with specificity toward phosphatidylethanolamine and phosphatidylcholine was previously purified, cloned and named lysosomal phospholipase A2 (LPLA2). LPLA2 transfers sn-1 or sn-2 acyl groups of phospholipids to the C1 hydroxyl of the short chain ceramide N-acetylsphingosine (NAS) under acidic conditions. The common features of lipophilic alcohols serving as acceptor molecules in the transacylase reaction were examined. 1-O-Hexadecyl-2-acetyl-sn-glycerol (HAG) was acylated by LPLA2 in similar to NAS. HAG competed with NAS and inhibited NAS acylation. The transacylation of 1-O-hexadecyl-glycerol (HG), 1-O-palmityl-2-O-methyl-sn-glycerol (PMG) and monoacylglycerols was also investigated.
Introduction
A novel acidic PLA2 activity was found in MDCK cell homogenates (1) . This activity was recovered in the soluble fraction and localized to lysosomes (2) . The enzyme displayed both transacylase and PLA2 activities and a preference for PE and PC as substrate when compared to other phospholipids (1) . LPLA2 was purified from bovine brain and was characterized as a water-soluble glycoprotein consisting of a single polypeptide chain with a molecular weight of 45 kDa (3) . The purified protein retained the characteristics of an acidic Ca 2+ -independent PLA2 and with transacylase. Protein and nucleotide sequencing demonstrated that LPLA2 is encoded by the same gene as lecithin: cholesterol acyltransferase like lysophospholipase (LLPL), and that the primary structure of LPLA2 is highly preserved between mammals (2, 4) . Because the lysophospholipase activity of the enzyme is very low in comparison to the phospholipase A2 activity, we have proposed LPLA2 as the preferred nomenclature.
LPLA2 is post-translationally modified both by a signal peptide cleavage and N-glycosylation (2) . The amino acid sequence of LPLA2 has 49% identity to lecithin: cholesterol acyltransferase (LCAT) and belongs to the -hydrolase superfamily. The catalytic triad and four cysteine residues conserved in LPLA2 are preserved in LCAT (2, 5) .
LPLA2 is now termed the group XV phospholipase A2 (6).
LPLA2 is most highly expressed in alveolar macrophages (AM) (7) . The LPLA2 activity and protein expression is extremely low in alveolar macrophages from GM-CSF -/-mice, a model of pulmonary alveolar proteinosis. LPLA2 -/-mice generated by systemic deletion of LPLA2 gene exon 5, which encodes the catalytic site, lost LPLA2 activity systemically (8) . A marked accumulation of phospholipid, in particular, PE and PC, was found in AM, peritoneal macrophages (PM) and spleen in LPLA2 -/-mice at an early stage.
Ultrastructural analysis revealed extensive lamellar inclusion bodies, a hallmark of cellular phospholipidosis, in the LPLA2 -/-mouse AM and PM. LPLA2 may therefore play a critical role in cellular phospholipid homeostasis in those macrophages.
The fact that LPLA2 possesses transacylase activity as well as PLA2 activity suggests an alternative role for LPLA2 besides phospholipid homeostasis. There are many by guest, on September 21, 2017 www.jlr.org Downloaded from biosynthetic and synthetic bioactive lipophilic alcohols, some of whose activities may be modulated via acylation of hydroxyl group in those alcohols. Ceramide is one of the natural bioactive lipophilic alcohols and is involved in cell growth, proliferation, differentiation, development and apoptosis (9, 10) . N-acetyl-D-erythro-sphingosine (NAS) known as C2
ceramide has been used to mimic the effect of ceramide on cell for long time among many researchers. Our previous report showed that NAS is a favorable acceptor in the transacylation reaction by LPLA2 (1) . On the contrary, a long acyl chain ceramide was acylated by the enzyme but behaves poorly as an acceptor in an in vitro assay. Other bioactive lipophilic alcohols such as diolein and sphingosine were also observed to be poor acceptors. These results suggest that the acceptor molecules used in the transacylation reaction by LPLA2 have a common chemical structure. Based on an ethanol structure, it was proposed that at least one long carbon chain group and one small neutral residue linked to the C2 position of ethanol is requisite to be a preferred acyl acceptor for transacylation by the enzyme. In the present study we confirm the existence of this structural requirement for acceptor molecules in the transacylation reaction. We investigated the acylation of biosynthetic and synthetic lipophilic alcohols by using recombinant mouse LPLA2. We have also observed that LPLA2 cannot only deacylate acyl groups of acylated lipophilic alcohols but also transacylate acyl groups of acylated lipophilic alcohols to acceptor lipophilic alcohols. In addition, an accumulation of a certain lipophilic alcohol was found in MDCK cells treated with cationic amphiphilic drugs (CADs), which inhibit the transacylase activity of LPLA2 (11) . The present study suggests another role for LPLA2 in addition to that of phospholipid catabolism.
Materials and Methods

Reagents
1, 2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1-O-hexadecyl-2-acetyl-sn-glycerol (HAG) were purchased from Avanti. Amiodarone, 1-O-hexadecyl-rac-glycerol (HG), oleoylethanolamide (OEA), anandamide (AEA),
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2-palmitoylglycerol and 3-palmitoyl-sn-glycerol from Sigma. NAS was obtained from
Matreya. The BCA protein assay reagent was from Pierce. HPTLC silica gel plates, 10 x 20 cm, were from Merck. D-threo-1-phenyl-2-decanoylamino-3-morpholino-propanol (PDMP) was previously synthesized in our laboratory (12) .
Transacylase activity of LPLA2
The reaction mixture consisted of 40 mM sodium citrate (pH 4.5), 10 μg/ml BSA, 40 μM acceptor incorporated into phospholipid liposomes (DOPC/sulfatide/acceptor (10:1:3.2 in molar ratio)), and recombinant mouse LPLA2 (29 ng) in a total volume of 500 μl. The reaction was initiated by adding the enzyme, incubating for 5 to 30 min at 37 o C, and terminating the reaction by adding 3 ml of chloroform/methanol (2:1) plus 0.3 ml of 0.9 %(w/v) NaCl. The mixture was centrifuged for 5 min at room temperature. The resultant lower organic layer was transferred into another glass tube and dried down under a stream of nitrogen gas. The dried lipid was dissolved in 40 μl of chloroform/methanol MDCK cells seeded in a 6-well plate were grown in 2 ml of DMEM-F12 medium containing 10% FCS with 1x Antibiotic-antimyotic (Invitrogen). The cells were maintained in an incubator with 5% CO 2 at 37 o C. After reaching 90% confluency, the cells were treated with or without CADs as indicated in the figure legend.
After the treatment, the cells in each well were washed 3 times with 2 ml of cold PBS, scraped with 1 ml of cold PBS and transferred into a glass tube (12.5 x 130 mm).
Another 1 ml of PBS was used to recover the remaining cells in the dish. Five ml of methanol plus 2.5 ml of chloroform were added into the tube and sonicated briefly with a water-bath type sonicator. The mixture stood for 1 h and was centrifuged for 30 min at 2,000g at room temperature. The supernatant was transferred into a glass tube (12.5 x 160 mm), mixed with 2.5 ml of chloroform plus 2.5 ml of 0.9% NaCl and centrifuged for 5 min at 800g at room temperature. The resulting lower layer was washed twice with 2.5 ml of methanol plus 2 ml of 0.9% NaCl and then once with 2.5 ml of methanol plus 2 ml of water.
The lower organic layer was transferred into a glass tube (10 x 130 mm), dried down under a stream of nitrogen gas and used for lipid analysis.
Results
Acylation of HAG and inhibition of formation of 1-O-acyl-NAS by HAG
The transacylase reaction by LPLA2 was originally found when NAS was present with phospholipid in the reaction mixture (1). NAS, a synthetic short acyl chain ceramide, was noted to be a better acceptor of the transacylase reaction with PC or PE as donors than long acyl chain ceramides. NAS is a lipophilic alcohol with one primary alcohol residue and one small neutral residue (acetyl group) linked to the C2 position of a sphingol backbone.
However, NAS is less hydrophobic than natural ceramides that are characterized by the presence of a long acyl carbon chain. Conceivably, there are a number of natural and non-natural lipophilic alcohols that have a similar structure to NAS. Some of these lipophilic alcohols are bioactive and could serve as the acceptor in the transacylation reaction by LPLA2.
Purified recombinant mouse LPLA2 was used in the present study to evaluate this (Fig. 1A) . Because DOPC was used as a substrate in the assay system, the released fatty acid and the formed acyl-NAS were oleic acid and 1-O-oleoyl-NAS, respectively.
1-O-Hexadecyl-2-acetyl-sn-glycerol (HAG) is an alkylacylglycerol with a primary alcohol group at the C3 position. HAG is structurally very similar to NAS. As expected, the enzyme produced two main products when HAG co-existed with DOPC in the reaction mixture (Fig. 1A) . One product possessed the same mobility as free fatty acid on TLC plate (Fig. 1A) . The other, a non-polar product, was characterized by the highest mobility on the 
Acylation of 1-O-hexadecyl-rac-glycerol (HG), 1-O-palmityl-2-O-methyl-sn-glycerol (PMG) and monoacylglycerols
To more generally characterize the structural requirements of other alcohols as an acceptors in the transacylation by LPLA2, structurally similar lipophilic alcohols including 1-O-monoalkylglycerol, 1,2-dialkylglycerol, and monoacylglycerols to HAG were investigated. HG is an ether-lipid, monoalkylglycerol, with two hydroxyl groups located at the C2 position and at the C3 position. Free fatty acid and non-polar product were produced when the enzyme was incubated with liposomes containing HG ( Fig. 2A) . The non-polar product was degraded to methyl ester and the parent compound by alkaline methanolysis (data not shown). These findings suggest that the enzyme acylates the hydroxyl group at the C2 or C3 position of HG. The mobility of the alkaline labile product (R f 0.74) was lower than that of triacylglycerol (TAG, R f ca. 0.90) but slightly higher than that of 1,3-diacylglycerol (DAG, R f 0.70) in TLC assay ( Fig. 2A ). The mobility of 1,3-alkylacylglycerol is always greater than that of 1,3-DAG in the solvent system used in Fig. 2A . By contrast, the mobility of 1,2-alkylacylglycerol is lower than that of 1,3-DAG.
Thus, the product produced from HG by the enzyme is most likely to be 1-O-hexadecyl-3-oleoyl-rac-glycerol. These data indicate that the enzyme acylates the hydroxyl group at the C3 position in HG but not at the C2 position. The initial velocity of acyl-HG formation by the enzyme was 50% of that of acyl-NAS. HG also inhibited the transacylation of NAS by LPLA2 in a dose dependent manner with an IC 50 at 35 μM ( Fig.   2D ).
PMG is a 1, 2-dialkylglycerol and the hydrophobicity of the side chain at the C2
position of PMG appears to be between HAG and HG. As observed in the HAG and NAS studies, the enzyme converted PMG to a more non-polar product, which was alkaline unstable (data not shown). The non-polar product of the transacylation of PMG was (Fig. 2B) . The initial velocity of the acyl-PMG formation by the enzyme was 80% of that of acyl-NAS.
As expected from the results of HG and PMG, LPLA2 produced free fatty acid and a non-polar product when the reaction mixture liposomes consisted of phospholipid and monoacylglycerol (MAG) (Fig. 2C) . The non-polar product was converted to methyl ester and glycerol by alkaline-methanolysis (data not shown). The mobility of the non-polar products produced from 1-palmitoylglycerol and 3-palmitoylglycerol were the same as that observed with 1,3-DAG but not with 1,2-DAG by TLC analysis. On the contrary, the mobility of the non-polar product produced from 2-palmitoylglycerol was the same as that Fig. 2D ). These data suggest that a preferred acceptor molecule consists of a primary alcohol with one long carbon chain plus one small neutral residue with a weak hydrophobicity linked to the core carbon.
Acylation of glycerol by LPLA2
To confirm the selectivity of hydroxyl group in the acceptor molecule, a simpler alcohol was examined. Glycerol, unlike other simple alcohols such as methanol and ethanol, stabilizes protein in solution even when used with high concentrations. A preliminary study demonstrated that glycerol is very poor as an acceptor. However, the acylation of glycerol by LPLA2 was observed when a high concentration of glycerol (30% w/v) is used in the reaction mixture. The enzyme produced two compounds when it was incubated with liposomes in the presence of 30% of glycerol (Fig. 3A) . One product was free fatty acid.
The other product was an alkaline unstable compound that showed the same mobility as 1-MAG or 3-MAG, but not 2-MAG, by TLC analysis. These results indicate that the alkaline-unstable compound produced from glycerol by the enzyme is 1-MAG or 3-MAG.
Free fatty acid is not separated from DAG in the solvent system used in With the use of a different solvent system, we observed that 1-MAG or 3-MAG formed from glycerol by the enzyme is further acylated to 1,3-DAG but not 1, 2-DAG with time ( Fig. 3B ). These data suggest that the acylation of the acceptor molecule in the transacylase reaction occurs at a primary alcohol group but not secondary alcohol group. Consistent with this finding is the prior observation that cholesterol is a very poor acceptor in the transacylase reaction by LPLA2 in distinction to LCAT (2, 4) .
Structural requirement of acceptors
by guest, on September 21, 2017
www.jlr.org
Downloaded from
A common structural feature between NAS and other lipophilic alcohols that act as an acceptor of acyl group in the transacylation emerges from the present studies (Fig. 4) .
Position X in Fig. 4 
Acylation of other biosynthetic lipophilic alcohols by LPLA2
Acylethanolamides such as OEA and AEA are biosynthetic and neutral products that have one primary alcohol group and one long carbon chain group at the carbon position 1 and 2, respectively. According to the hypothesis for the structural requirement as shown in Fig. 4 , it was predicted that LPLA2 would acylate the hydroxyl group of acylethanolamides.
Indeed, the enzyme converted OEA and AEA to non-polar compounds with a higher mobility than their parent compounds in TLC assay (Fig. 5A) . The non-polar products produced from OEA and AEA were converted to OEA and methyl ester and AEA and methyl ester, respectively, by alkaline-methanolysis (data not shown). In this study, the 
Deacylation and transacylation of acyl group of alcohols acylated by LPLA2
In previous studies we observed that unlike fatty acids released from phospholipids by LPLA2, the levels of acyl compounds produced by LPLA2 always reach a certain plateau and gradually declined with time in the transacylase reaction (1, 3) . This observation suggested that there may be degradation of the acylated lipophilic alcohol produced in the reaction mixture. Therefore, the acyl-compound produced by LPLA2 was possibly deacylated by the same enzyme. To confirm the presence of the reverse reaction, the deacylation and transacylation of the acyl group of transacylated products produced by LPLA2 was investigated.
1-O-Palmitoyl-NAS, one of the acyl-compounds produced by LPLA2, was synthesized chemically and incorporated into liposomes. When liposomes containing DOPC and 1-O-palmitoyl-NAS were incubated with LPLA2, a substantial decrease of 1-O-palmitoyl-NAS and the generation of several products were noted by TLC assay using an argentation plate (Fig. 6A) . The main product in the reaction corresponded to oleic acid.
The other products corresponded to palmitic acid and 1-O-oleoyl-NAS. Although it was very hard to see all products in this assay, the band corresponded to NAS was identified as one of the reaction products by another TLC assay (data not shown). These results indicate that oleic acid was released from DOPC and palmitic acid and NAS were produced from 1-O-palmitoyl-NAS by LPLA2 activity. In addition, the formation of 1-O-oleoyl-NAS is interpreted to suggest that NAS produced from 1-O-palmitoyl-NAS by the enzyme can act as an acceptor of oleoyl group of DOPC in the transacylase reaction.
When the enzyme was incubated with diolein in the presence of NAS, three products were detected ( Fig. 6A and 6B ). One major product corresponded to 1-O-oleoyl-NAS. Although other two products were not obvious on the plate in the system in Fig. 6A , they corresponded to fatty acid and MAG by use of another solvent system (Fig.   6B ). Fatty acid was detected as a diffused band between 1,2-and 1,3-diolein bands and MAG as diffused doublet bands around MAG (Fig. 6B) . Fatty acid and MAG are therefore oleic acid and mono-oleoylglycerol, respectively. Additionally, the mono-oleoylglycerol produced by the enzyme appears to correspond primarily to 2-oleoylglycrol from the by guest, on September 21, 2017
www.jlr.org Downloaded from mobility. As expected from a broad positional specificity of LPLA2 to phospholipid acyl groups (13), the acyl group at the C2 as well as the C1 position of MAG was hydrolyzed or transferred to NAS by the enzyme (Fig. 6B ). In addition, LPLA2 catalyzes neither deacylation nor transacylation of acyl group of triacylglycerol (TGA) and cholesterol-ester (data not shown). Despite the ability of LPLA2 to deacylate MAG and DAG, LPLA2 failed to form DAG from MAG or TAG from DAG in the presence of NAS (Fig. 6B) .
Accumulation of lipophilic alcohol in MDCK cells treated with cationic amphiphilic drugs
Our previous study suggested that the inhibition of LPLA2 activity by CADs such amiodarone and PDMP contributes to the phospholipidosis induced by these CADs in MDCK cells (11) . PDMP and amiodarone inhibit the transacylase activity of LPLA2 in a dose dependent manner. Interestingly, MDCK cells treated with a concentration of CAD that induces cellular phospholipidosis showed an obvious increase of non-polar lipid as well as phospholipid (Fig. 7) . The mobility of the non-polar lipid that is comparable to that of HG was slightly higher than that of ceramide in TLC assay using a regular plate (Fig.   7A ). The non-polar lipid was completely separated from ceramide by using a borate treated plate and maintained the same mobility as HG (Fig. 7B ). These results demonstrate that the non-polar lipid corresponds to 1-O-alkylglycerol and suggest that an accumulation of a certain lipophilic alcohol induced by CAD in the cell is associated with inhibition of the transacylase activity of LPLA2 by CAD.
Discussion
Previous studies demonstrated that LPLA2 possesses dual enzyme activities, a transacylase and a phospholipase A2 activity (1, 2, 3) . A site-directed mutagenesis study of LPLA2
showed that the enzyme has a putative catalytic triad structure consisting of three amino acid residues, serine, aspartic acid and histidine, which is an essential for hydrolysis reaction (5). These studies indicated that the enzyme may form an acyl-enzyme intermediate via the catalytic serine residue of the triad in the transition state of deacylation of phospholipid. The acyl group of the intermediate is transferred to a hydroxyl group of water and alcohol to form free fatty acid and ester, respectively (2, 5) . A similar enzymatic mechanism has been proposed for cytosolic phospholipase A2 (cPLA2) (14) (15) (16) . cPLA2
catalyzes a transacylase reaction as well as a deacylase reaction when the phospholipase assay is carried out in the presence of glycerol. The product of the transacylation reaction is MAG and the acyl group is predominantly esterified to a primary alcohol group of glycerol as observed in our study (16) .
The present study demonstrate that the acceptor molecules in the transacylase reaction by LPLA2 may be viewed as simple derivatives of ethanol required to possess one long carbon chain group and one small neutral residue linked at the C2 position of ethanol.
Indeed, the transacylase activity of LPLA2 was observed when lipophilic alcohols were incubated with phospholipids under acidic conditions. In this reaction the enzyme had a much greater preference for a primary alcohol as the acceptor of acyl group than secondary alcohol, suggesting that the transacylation of alcohol by the enzyme is greatly dependent on the nucleophilicity of the hydroxyl group of acceptor alcohol. Although inhibition of Some acceptor alcohols used in this study are biologically active. NAS, a synthetic short acyl chain ceramide, is a better acceptor of the acyl group deacylated from PC or PE in the transacylase reaction than long acyl chain ceramides (1) . NAS has been used in many studies as a substitute for ceramide, which is thought to be an important effector molecule in some signal transduction processes (9, 10) . Recently, it was reported that NAS is synthesized from PAF and sphingosine via the transacetylase in HL-60 cells (22) . HAG is an alkylacylglycerol with a primary alcohol group and known as a biosynthetic precursor of platelet activating factor via remodeling and retro-conversion de novo routes (23) . HAG induces an inhibition of protein kinase C activation by DAG (24, 25) , a stimulation of HL-60 cell differentiation (26) and a delayed aggregation of rabbit platelets (27) . HG is found as a constituent of certain ether-linked phospholipids such as PAF. HG is a 1-O-alkylglycerol and shows noticeable biological effects as described above. 
